Company Profiles

driven by the PitchBook Platform

Cognoptix

Description

Developer of non-invasive diagnostic platform. The company manufactures products for sensitive measurements of biophysical changes in the eye, including non-invasive instruments for diagnosis and monitoring Alzheimer's disease.

2001

Founded

PRIVATE

Status

1-10

Employees

Angel

Latest Deal Type

$20k

Latest Deal Amount

$41.8M

Total Amount Raised

Description

Developer of non-invasive diagnostic platform. The company manufactures products for sensitive measurements of biophysical changes in the eye, including non-invasive instruments for diagnosis and monitoring Alzheimer's disease.

Website:

www.cognoptix.com

Formerly Known As

Neuroptix

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Diagnostic Equipment

Primary Office

100 Main Street Suite 110 Concord, MA 01742United States +1 (978) 263-0005
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Cognoptix's full profile, request a free trial.

Cognoptix Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Cognoptix Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Cognoptix Investors (10)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Alopexx EnterprisesCorporate Venture CapitalMinority000 0000000 0000
Beacon AngelsVenture CapitalMinority000 0000000 0000
Boston Harbor AngelsAngel GroupMinority000 0000000 0000
Individual InvestorAngel (individual)Minority000 0000000 0000
Inventages Venture CapitalVenture CapitalMinority000 0000000 0000
Alopexx Enterprises Corporate Venture Capital
Beacon Angels Venture Capital
Boston Harbor Angels Angel Group
Individual Investor Angel (individual)
Inventages Venture Capital Venture Capital

Cognoptix Executive Team (8)

NameTitleBoard
Seat
Contact
Info
Anne Cameron Ph.DDirector, Marketing and Clinical Strategy
Charles Kerbage Ph.DDirector, Research & Development
Lee Goldstein Ph.DCo-Founder
Leo ChylackCo-Founder
Daniel Vlock MDChief Executive Officer
Anne Cameron Ph.D Director, Marketing and Clinical Strategy
Charles Kerbage Ph.D Director, Research & Development
Lee Goldstein Ph.D Co-Founder
Leo Chylack Co-Founder
Daniel Vlock MD Chief Executive Officer

Cognoptix Board Members (5)

NameRepresentingRoleSinceContact
Info
Christine de los ReyesAlopexx EnterprisesVice President, Business Development and Strategic Planning000 0000
Gunnar Weikert Ph.DSelfChairman000 0000
Oliver Hofmann Ph.DInventages Venture CapitalInvestment Manager000 0000
Richard Gill Ph.DSelfBoard Member000 0000
Werner Schaefer Ph.DSelfBoard Member000 0000
Christine de los Reyes Vice President, Business Development and Strategic Planning Alopexx Enterprises
Gunnar Weikert Ph.D Chairman Self
Oliver Hofmann Ph.D Investment Manager Inventages Venture Capital
Richard Gill Ph.D Board Member Self
Werner Schaefer Ph.D Board Member Self
Request full access to PitchBook